199730 — BioInfra Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩42bn
- KR₩34bn
- KR₩30bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | — | 4,191 | 6,234 | 6,237 | 2,002 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | — | -417 | 1,335 | 967 | 114 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 5,041 | -544 | -2,185 | -757 | -3,822 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 5,041 | 4,171 | 6,563 | 8,425 | 679 |
Capital Expenditures | -2,712 | -2,321 | -14,425 | -10,681 | -3,698 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -980 | -5.8 | -479 | 10,560 | -6,999 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,692 | -2,327 | -14,904 | -121 | -10,696 |
Financing Cash Flow Items | — | — | — | -6.6 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1,053 | 2,249 | 6,948 | -6,723 | 13,349 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,402 | 4,093 | -1,393 | 1,580 | 3,332 |